speb/financial-data huggingface dataset:
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 140000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 128000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Properties: 129112000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Receivables: 31345000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Payables: 57260000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 57260000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 14200000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Business: -16364000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Intangibles: -1273000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -4424000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Receivables: 122385000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 51706000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 1738000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -1252000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Restructuring And Mergern Acquisition: 1379000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 99971000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Selling General And Administration: 3091000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Share Issued: 28553156.00
DRX.TO income_statement (quarterly, 2025-10-31) — Special Income Charges: -1379000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: -1704000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 181191000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 174015000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: -571045.35
DRX.TO income_statement (quarterly, 2025-10-31) — Tax Provision: 3891000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.27
DRX.TO balance_sheet (quarterly, 2025-10-31) — Taxes Receivable: 5135000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Taxes Refund Paid: -5577000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Assets: 317654000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 216414000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Debt: 42740000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 181191000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Total Expenses: 54797000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 136463000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 136428000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 56630000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 0.00
DRX.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items: -2084000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: -2084000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Working Capital: 101393000.00
DRX.TO income_statement (annual, 2026-01-31) — +Operating Expense: 23191000.00
DRX.TO income_statement (quarterly, 2026-01-31) — +Operating Expense: 7905000.00
DRX.TO income_statement (annual, 2026-01-31) — +Total Revenue: 258736000.00
DRX.TO income_statement (quarterly, 2026-01-31) — +Total Revenue: 78794000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Accounts Payable: 24398000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 24398000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Accounts Receivable: 54707000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 54707000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Accumulated Depreciation: -75047000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -75047000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Additional Paid In Capital: 5958000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 5958000.00
DRX.TO cash_flow (annual, 2026-01-31) — Amortization Cash Flow: 630000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Amortization Cash Flow: 173000.00
DRX.TO cash_flow (annual, 2026-01-31) — Amortization Of Intangibles: 630000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Amortization Of Intangibles: 173000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Assets Held For Sale Current: 836000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Assets Held For Sale Current: 836000.00
DRX.TO income_statement (annual, 2026-01-31) — Basic Average Shares: 28426000.00
DRX.TO income_statement (annual, 2026-01-31) — Basic EPS: 0.93
DRX.TO cash_flow (annual, 2026-01-31) — Beginning Cash Position: 59983000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 32707000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Buildings And Improvements: 108843000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Buildings And Improvements: 108843000.00
DRX.TO cash_flow (annual, 2026-01-31) — Capital Expenditure: -11068000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -2346000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Capital Lease Obligations: 2931000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 2931000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Capital Stock: 62541000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Capital Stock: 62541000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Cash And Cash Equivalents: 62729000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 62729000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 62729000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 62729000.00
DRX.TO cash_flow (annual, 2026-01-31) — Cash Dividends Paid: -1146000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: 0.00
DRX.TO cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Financing Activities: -16815000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -2561000.00
DRX.TO cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Investing Activities: -27273000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -2262000.00
DRX.TO cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Operating Activities: 49417000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 36019000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Account Payable: -893000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -732000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Inventory: -2813000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Inventory: -239000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Other Current Assets: -2730000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Other Working Capital: 6147000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 5538000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Payable: -893000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Payable: -732000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Payables And Accrued Expense: -893000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -732000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Prepaid Assets: 264000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 2871000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Receivables: 25037000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Receivables: 19160000.00
DRX.TO cash_flow (annual, 2026-01-31) — Change In Working Capital: 25012000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 23868000.00
DRX.TO cash_flow (annual, 2026-01-31) — Changes In Account Receivables: 14599000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: 10353000.00
DRX.TO cash_flow (annual, 2026-01-31) — Changes In Cash: 5329000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Changes In Cash: 31196000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Common Stock: 62541000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Common Stock: 62541000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Common Stock Equity: 183605000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 183605000.00
DRX.TO cash_flow (annual, 2026-01-31) — Common Stock Payments: -9001000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Common Stock Payments: -1077000.00
DRX.TO income_statement (annual, 2026-01-31) — Cost Of Revenue: 198964000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 61869000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Accrued Expenses: 25298000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 25298000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Assets: 191566000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Assets: 191566000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Capital Lease Obligation: 893000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 893000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Debt And Capital Lease Obligation: 5165000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 5165000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Deferred Liabilities: 21838000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 21838000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Deferred Revenue: 21838000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 21838000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Current Liabilities: 86767000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 86767000.00
DRX.TO cash_flow (annual, 2026-01-31) — Deferred Income Tax: 10162000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: 3717000.00
DRX.TO cash_flow (annual, 2026-01-31) — Deferred Tax: 10162000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Deferred Tax: 3717000.00
DRX.TO cash_flow (annual, 2026-01-31) — Depreciation: 6290000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Depreciation: 1857000.00
DRX.TO cash_flow (annual, 2026-01-31) — Depreciation Amortization Depletion: 6920000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 2030000.00
DRX.TO cash_flow (annual, 2026-01-31) — Depreciation And Amortization: 6920000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 2030000.00
DRX.TO income_statement (annual, 2026-01-31) — Diluted Average Shares: 28426000.00
DRX.TO income_statement (annual, 2026-01-31) — Diluted EPS: 0.93
DRX.TO income_statement (annual, 2026-01-31) — Diluted NI Availto Com Stockholders: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 6358000.00
DRX.TO income_statement (annual, 2026-01-31) — EBIT: 38406000.00
DRX.TO income_statement (quarterly, 2026-01-31) — EBIT: 16813000.00
DRX.TO income_statement (annual, 2026-01-31) — EBITDA: 45326000.00
DRX.TO income_statement (quarterly, 2026-01-31) — EBITDA: 18843000.00
DRX.TO cash_flow (annual, 2026-01-31) — Effect Of Exchange Rate Changes: -2583000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: -1174000.00
DRX.TO cash_flow (annual, 2026-01-31) — End Cash Position: 62729000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — End Cash Position: 62729000.00
DRX.TO cash_flow (annual, 2026-01-31) — Financing Cash Flow: -16815000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -2561000.00
DRX.TO cash_flow (annual, 2026-01-31) — Free Cash Flow: 38349000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 33673000.00
DRX.TO cash_flow (annual, 2026-01-31) — Gain Loss On Investment Securities: -7662000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: -869000.00
DRX.TO income_statement (annual, 2026-01-31) — Gain On Sale Of Security: 2148000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 737000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 8705000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 8705000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Goodwill: 97000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Goodwill: 97000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Goodwill And Other Intangible Assets: 8442000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 8442000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Gross PPE: 201932000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Gross PPE: 201932000.00
DRX.TO income_statement (annual, 2026-01-31) — Gross Profit: 59772000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Gross Profit: 16925000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Hedging Assets Current: 465000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Hedging Assets Current: 465000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Income Tax Payable: 1634000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 1634000.00
DRX.TO income_statement (annual, 2026-01-31) — Interest Expense: 2613000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Interest Expense: 2190000.00
DRX.TO income_statement (annual, 2026-01-31) — Interest Expense Non Operating: 2613000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 2190000.00
DRX.TO income_statement (annual, 2026-01-31) — Interest Income: 1871000.00
DRX.TO income_statement (annual, 2026-01-31) — Interest Income Non Operating: 1871000.00
DRX.TO cash_flow (annual, 2026-01-31) — Interest Paid Cff: -1925000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Interest Paid Cff: -401000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Inventories Adjustments Allowances: -1501000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Inventories Adjustments Allowances: -1501000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Inventory: 19568000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Inventory: 19568000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Invested Capital: 218030000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Invested Capital: 218030000.00
DRX.TO cash_flow (annual, 2026-01-31) — Investing Cash Flow: -27273000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -2262000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Land And Improvements: 9322000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Land And Improvements: 9322000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Long Term Capital Lease Obligation: 2038000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 2038000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Long Term Debt: 34425000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 34425000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 36463000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 36463000.00
DRX.TO cash_flow (annual, 2026-01-31) — Long Term Debt Payments: -4743000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -1083000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Machinery Furniture Equipment: 10991000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 10991000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Business Purchase And Sale: -16381000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: -17000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Common Stock Issuance: -9001000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: -1077000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Foreign Currency Exchange Gain Loss: 2525000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Foreign Currency Exchange Gain Loss: 671000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income: 6358000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income Common Stockholders: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 6358000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income Continuous Operations: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 12358000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 6358000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 6358000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Income From Continuing Operations: 26311000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 6358000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Income Including Noncontrolling Interests: 26311000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 12358000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Intangibles Purchase And Sale: -3666000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Intangibles Purchase And Sale: -958000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Interest Income: -827000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Interest Income: -404000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Issuance Payments Of Debt: -4743000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: -1083000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Long Term Debt Issuance: -4743000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: -1083000.00
DRX.TO income_statement (annual, 2026-01-31) — Net Non Operating Interest Income Expense: -827000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -404000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net Other Investing Changes: 176000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 101000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Net PPE: 126885000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Net PPE: 126885000.00
DRX.TO cash_flow (annual, 2026-01-31) — Net PPE Purchase And Sale: -7402000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -1388000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Net Tangible Assets: 175163000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 175163000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Non Current Deferred Assets: 1647000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 1647000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Non Current Deferred Liabilities: 21715000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 21715000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Non Current Deferred Taxes Assets: 1647000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 1647000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Non Current Deferred Taxes Liabilities: 21715000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 21715000.00
DRX.TO income_statement (annual, 2026-01-31) — Normalized EBITDA: 45287000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 18836000.00
DRX.TO income_statement (annual, 2026-01-31) — Normalized Income: 26282335.00
DRX.TO income_statement (quarterly, 2026-01-31) — Normalized Income: 6352084.25
DRX.TO cash_flow (annual, 2026-01-31) — Operating Cash Flow: 49417000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 36019000.00
DRX.TO cash_flow (annual, 2026-01-31) — Operating Gains Losses: -5137000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -198000.00
DRX.TO income_statement (annual, 2026-01-31) — Operating Income: 36581000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Operating Income: 9020000.00
DRX.TO income_statement (annual, 2026-01-31) — Operating Revenue: 258736000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Operating Revenue: 78794000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Ordinary Shares Number: 28553156.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 28553156.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Current Assets: 3451000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 3451000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Equity Adjustments: 8705000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 8705000.00
DRX.TO income_statement (annual, 2026-01-31) — Other Income Expense: 39000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Other Income Expense: 7000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Intangible Assets: 8345000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 8345000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Inventories: 21069000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Inventories: 21069000.00
DRX.TO cash_flow (annual, 2026-01-31) — Other Non Cash Items: 2415000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 550000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Non Current Assets: 135000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 135000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Non Current Liabilities: 125000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 125000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Properties: 72776000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Properties: 72776000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Other Receivables: 40710000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Other Receivables: 40710000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Payables: 27173000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Payables: 27173000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Payables And Accrued Expenses: 52471000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 52471000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 7293000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 7293000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Prepaid Assets: 3822000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 3822000.00
DRX.TO income_statement (annual, 2026-01-31) — Pretax Income: 35793000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Pretax Income: 14623000.00
DRX.TO cash_flow (annual, 2026-01-31) — Provisionand Write Offof Assets: -294000.00
DRX.TO cash_flow (annual, 2026-01-31) — Purchase Of Business: -16381000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Business: -17000.00
DRX.TO cash_flow (annual, 2026-01-31) — Purchase Of Intangibles: -3666000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Intangibles: -958000.00
DRX.TO cash_flow (annual, 2026-01-31) — Purchase Of PPE: -7402000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -1388000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Receivables: 100695000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Receivables: 100695000.00
DRX.TO income_statement (annual, 2026-01-31) — Reconciled Cost Of Revenue: 198964000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 61869000.00
DRX.TO income_statement (annual, 2026-01-31) — Reconciled Depreciation: 6920000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 2030000.00
DRX.TO cash_flow (annual, 2026-01-31) — Repayment Of Debt: -4743000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -1083000.00
DRX.TO cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: -9001000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: -1077000.00
DRX.TO income_statement (annual, 2026-01-31) — Restructuring And Mergern Acquisition: 2109000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 730000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Retained Earnings: 106401000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 106401000.00
DRX.TO income_statement (annual, 2026-01-31) — Selling General And Administration: 23191000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Selling General And Administration: 7905000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Share Issued: 28553156.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Share Issued: 28553156.00
DRX.TO income_statement (annual, 2026-01-31) — Special Income Charges: -2109000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Special Income Charges: -730000.00
DRX.TO cash_flow (annual, 2026-01-31) — Stock Based Compensation: 987000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 1474000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Stockholders Equity: 183605000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 183605000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Tangible Book Value: 175163000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 175163000.00
DRX.TO income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: 10335.00
DRX.TO income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 1084.25
DRX.TO income_statement (annual, 2026-01-31) — Tax Provision: 9482000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Tax Provision: 2265000.00
DRX.TO income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.27
DRX.TO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.15
DRX.TO balance_sheet (annual, 2026-01-31) — Taxes Receivable: 5278000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 5278000.00
DRX.TO cash_flow (annual, 2026-01-31) — Taxes Refund Paid: -16959000.00
DRX.TO cash_flow (quarterly, 2026-01-31) — Taxes Refund Paid: -1486000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Assets: 328675000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Assets: 328675000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Capitalization: 218030000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 218030000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Debt: 41628000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Debt: 41628000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 183605000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 183605000.00
DRX.TO income_statement (annual, 2026-01-31) — Total Expenses: 222155000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Total Expenses: 69774000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 145070000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 145070000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 137109000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 137109000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 58303000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 58303000.00
DRX.TO income_statement (annual, 2026-01-31) — Total Other Finance Cost: 85000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Total Tax Payable: 2775000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 2775000.00
DRX.TO income_statement (annual, 2026-01-31) — Total Unusual Items: 39000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items: 7000.00
DRX.TO income_statement (annual, 2026-01-31) — Total Unusual Items Excluding Goodwill: 39000.00
DRX.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 7000.00
DRX.TO balance_sheet (annual, 2026-01-31) — Working Capital: 104799000.00
DRX.TO balance_sheet (quarterly, 2026-01-31) — Working Capital: 104799000.00
DRX.TO income_statement (quarterly, 2026-04-30) — +Operating Expense: 7615000.00
DRX.TO income_statement (quarterly, 2026-04-30) — +Total Revenue: 99261000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 70455000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 80513000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 5958000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Amortization Cash Flow: 179000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Amortization Of Intangibles: 179000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Assets Held For Sale Current: 836000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Basic Average Shares: 28553000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Basic EPS: 0.42
DRX.TO cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 62729000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -9038000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 2743000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Capital Stock: 62541000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 62125000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 62125000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Cash Dividends Paid: 0.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -1966000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -8883000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 10081000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 12059000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Inventory: 936000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: -1614000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -7932000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Payable: 12059000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 12059000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -76000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Receivables: -13506000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -10133000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: -7036000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Changes In Cash: -768000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Common Stock: 62541000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 195573000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Common Stock Payments: 0.00
DRX.TO income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 75236000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Assets: 205052000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 910000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 5179000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 14061000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 14061000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 93152000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: 4437000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Deferred Tax: 4437000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Depreciation: 1898000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 2077000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 2077000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 28553000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.42
DRX.TO income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — EBIT: 16781000.00
DRX.TO income_statement (quarterly, 2026-04-30) — EBITDA: 18858000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: 164000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — End Cash Position: 62125000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -1966000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 1043000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Gain Loss On Investment Securities: -544000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 371000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 9207000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Goodwill: 97000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 9303000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Gross PPE: 131115000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Gross Profit: 24025000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Hedging Assets Current: 1010000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Interest Expense: 307000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 307000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Interest Paid Cff: -472000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Inventory: 18656000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Invested Capital: 228765000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -8883000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 1833000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 33192000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 35025000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -1494000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 0.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Foreign Currency Exchange Gain Loss: -2000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 12037000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 12037000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 12037000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Intangibles Purchase And Sale: -1768000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Interest Income: -307000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -1494000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -1494000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -307000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 155000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Net PPE: 131115000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -7270000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 186270000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Assets: 797000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 22524000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Assets: 797000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 22524000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 18487000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Normalized Income: 11765922.73
DRX.TO cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 10081000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -546000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Operating Income: 16410000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Operating Revenue: 99261000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 28553156.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 5065000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: 9207000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Other Income Expense: 371000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 9206000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 496000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 129000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 122000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Properties: 131115000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Other Receivables: 28628000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Payables: 73912000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 73912000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 3894000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Pretax Income: 16474000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Purchase Of Intangibles: -1768000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -7270000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Receivables: 113466000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 75236000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 2077000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -1494000.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: 0.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 117867000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Selling General And Administration: 7615000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Share Issued: 28553156.00
DRX.TO cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 1713000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 195573000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 186270000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 99922.73
DRX.TO income_statement (quarterly, 2026-04-30) — Tax Provision: 4437000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.27
DRX.TO balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 4325000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Assets: 346396000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 228765000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Debt: 40204000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 195573000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Total Expenses: 82851000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 150823000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 141344000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 57671000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 3457000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items: 371000.00
DRX.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 371000.00
DRX.TO balance_sheet (quarterly, 2026-04-30) — Working Capital: 111900000.00
DRY.V income_statement (annual, 2022-12-31) — +Operating Expense: 472853.00
DRY.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 4769.00
DRY.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 0.00
DRY.V income_statement (annual, 2022-12-31) — Basic Average Shares: 82845041.00
DRY.V income_statement (annual, 2022-12-31) — Basic EPS: 0.00
DRY.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 620030.00
DRY.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -1091043.00
DRY.V balance_sheet (annual, 2022-12-31) — Capital Stock: 2596445.00
DRY.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 202532.00
DRY.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 202532.00
DRY.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1106445.00
DRY.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1091043.00
DRY.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -432900.00
DRY.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 24806.00
DRY.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 0.00
DRY.V cash_flow (annual, 2022-12-31) — Change In Receivables: -5265.00
DRY.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 19541.00
DRY.V cash_flow (annual, 2022-12-31) — Changes In Cash: -417498.00
DRY.V balance_sheet (annual, 2022-12-31) — Common Stock: 2596445.00
DRY.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2312163.00
DRY.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1106445.00
DRY.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 22500.00
DRY.V balance_sheet (annual, 2022-12-31) — Current Assets: 208389.00
DRY.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 27269.00
DRY.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 82845041.00
DRY.V income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
DRY.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -282441.00
DRY.V income_statement (annual, 2022-12-31) — EBIT: -472853.00
DRY.V income_statement (annual, 2022-12-31) — EBITDA: -472853.00
DRY.V cash_flow (annual, 2022-12-31) — End Cash Position: 202532.00
DRY.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1106445.00
DRY.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -1523943.00
DRY.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 53637.00
DRY.V income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
DRY.V income_statement (annual, 2022-12-31) — Interest Income: 412.00
DRY.V income_statement (annual, 2022-12-31) — Interest Income Non Operating: 412.00
DRY.V balance_sheet (annual, 2022-12-31) — Invested Capital: 2312163.00
DRY.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1091043.00
DRY.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1106445.00
DRY.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1106445.00
DRY.V income_statement (annual, 2022-12-31) — Net Income: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -282441.00
DRY.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -282441.00
DRY.V income_statement (annual, 2022-12-31) — Net Interest Income: 412.00
DRY.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 412.00
DRY.V balance_sheet (annual, 2022-12-31) — Net PPE: 2131043.00
DRY.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1091043.00
DRY.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2312163.00
DRY.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 0.00
DRY.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -472853.00
DRY.V income_statement (annual, 2022-12-31) — Normalized Income: -282441.00
DRY.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -432900.00
DRY.V income_statement (annual, 2022-12-31) — Operating Income: -472853.00
DRY.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 82845041.00
DRY.V income_statement (annual, 2022-12-31) — Other Gand A: 53637.00
DRY.V income_statement (annual, 2022-12-31) — Other Income Expense: 190000.00
DRY.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: -170000.00
DRY.V income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 190000.00
DRY.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 419216.00
DRY.V balance_sheet (annual, 2022-12-31) — Payables: 4769.00
DRY.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 27269.00
DRY.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 0.00
DRY.V income_statement (annual, 2022-12-31) — Pretax Income: -282441.00
DRY.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1091043.00
DRY.V balance_sheet (annual, 2022-12-31) — Receivables: 5857.00
DRY.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -284282.00
DRY.V income_statement (annual, 2022-12-31) — Salaries And Wages: 0.00
DRY.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 0.00
DRY.V income_statement (annual, 2022-12-31) — Selling General And Administration: 53637.00
DRY.V balance_sheet (annual, 2022-12-31) — Share Issued: 82845041.00
DRY.V income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
DRY.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2312163.00
DRY.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2312163.00
DRY.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
DRY.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 5857.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Assets: 2339432.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 2312163.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2312163.00
DRY.V income_statement (annual, 2022-12-31) — Total Expenses: 472853.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27269.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2131043.00
DRY.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
DRY.V income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
DRY.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
DRY.V balance_sheet (annual, 2022-12-31) — Working Capital: 181120.00
DRY.V income_statement (annual, 2023-12-31) — +Operating Expense: 3594860.00
DRY.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
DRY.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 509134.00
DRY.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: 0.00
DRY.V balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 481935.00
DRY.V cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 0.00
DRY.V cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 0.00
DRY.V income_statement (annual, 2023-12-31) — Basic Average Shares: 33270036.00